1. Market Research
  2. > Healthcare Market Trends
  3. > Healthcare Analysis & Statistics, December 2016 (p50)

Healthcare Analysis & Statistics, December 2016 (p50)

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

All regions

1471-1500 of about 41000 reports

Purchase Reports From Reputable Market Research Publishers

Interleukin 15 Receptor Subunit Alpha (CD215 or IL15RA) - Pipeline Review, H2 2016

Interleukin 15 Receptor Subunit Alpha (CD215 or IL15RA) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Interleukin 15 Receptor Subunit Alpha (CD215 or IL15RA) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 15 Receptor Subunit Alpha (CD215 or IL15RA) - Pipeline Review, H2 2016’, ...

  • Industries : Cancer, Therapy, Pathology, Biological Therapy
  • Countries : United States
CA Tumor Markers 2017-2021: CA 15-3/27.29, CA 19-9, CA 125--US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review

CA Tumor Markers 2017-2021: CA 15-3/27.29, CA 19-9, CA 125--US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review

  • $ 3500
  • Industry report
  • December 2016
  • by Venture Planning Group

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the ...

  • Industries : Diagnostics
2017-2021 Coagulation Testing in Hospitals, Private Labs, and POC Locations--Supplier Shares, Country Volume and Sales Forecasts

2017-2021 Coagulation Testing in Hospitals, Private Labs, and POC Locations--Supplier Shares, Country Volume and Sales Forecasts

  • $ 3500
  • Industry report
  • December 2016
  • by Venture Planning Group

This report provides a worldwide overview of the coagulation testing market, including estimates of facilities performing coagulation tests, as well as test volume and sales forecasts for coagulation reagents ...

  • Industries : In Vitro Diagnostics
  • Countries : World
Pap Smear/Human Papillomavirus (HPV) 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review

Pap Smear/Human Papillomavirus (HPV) 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review

  • $ 3500
  • Industry report
  • December 2016
  • by Venture Planning Group

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the ...

  • Industries : In Vitro Diagnostics
HIV/AIDS Diagnostics Market 2017-2021: US, Europe, Japan--Opportunities for Instrument and Reagent Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review

HIV/AIDS Diagnostics Market 2017-2021: US, Europe, Japan--Opportunities for Instrument and Reagent Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review

  • $ 3500
  • Industry report
  • December 2016
  • by Venture Planning Group

The report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology ...

  • Industries : Pathology
  • Countries : Europe, Japan
Cytomegalovirus (CMV) 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review

Cytomegalovirus (CMV) 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review

  • $ 3500
  • Industry report
  • December 2016
  • by Venture Planning Group

The report presents a detailed analysis of the Cytomegalovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the CMV definition, epidemiology ...

  • Industries : Pathology
  • Countries : Europe, Japan
Market Analysis of Hemostat Powder Industry in China 2016-2020

Market Analysis of Hemostat Powder Industry in China 2016-2020

  • $ 3500
  • Industry report
  • December 2016
  • by AskCI Consulting Co.

Hemostat Powder refers to medical material in powder forms, which can realize hemostasis by accelerating blood coagulation. As the popularization of surgical treatment method, hemostat powder gets more ...

  • Industries : Medical Supply
  • Countries : China
Global Dental 3D Scanners Market Assessment & Forecast: 2016 - 2020

Global Dental 3D Scanners Market Assessment & Forecast: 2016 - 2020

  • $ 3500
  • Industry report
  • December 2016
  • by Spearhead Acuity

The Asia-Pacific Dental 3D Scanners market is forecast to grow at a CAGR of 8.2% from 2016 to 2020 and in 2015 was valued at US$ 102.2 million, according to the new report “Global Dental 3D Scanners ...

  • Industries : IT Infrastructure
  • Countries : World
Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Pipeline Review, H2 2016

Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) ...

  • Industries : Therapy, Pathology, Biopharmaceutical, Healthcare
  • Countries : United States
RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) - Pipeline Review, H2 2016

RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘RAF Proto Oncogene Serine/Threonine Protein ...

  • Industries : Therapy, Cancer, Pathology, Pharmaceutical
  • Countries : United States
Aurora Kinase B (Aurora 1 or Aurora And IPL1 Like Midbody Associated Protein 1 or Serine/Threonine Protein Kinase 12 or Serine/Threonine Protein Kinase 5 or Serine/Threonine Protein Kinase Aurora B or STK1 or AURKB or EC 2.7.11.1) - Pipeline Review, H2 20

Aurora Kinase B (Aurora 1 or Aurora And IPL1 Like Midbody Associated Protein 1 or Serine/Threonine Protein Kinase 12 or Serine/Threonine Protein Kinase 5 or Serine/Threonine Protein Kinase Aurora B or STK1 or AURKB or EC 2.7.11.1) - Pipeline Review, H2 20

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Aurora Kinase B (Aurora 1 or Aurora And IPL1 Like Midbody Associated Protein 1 or Serine/Threonine Protein Kinase 12 or Serine/Threonine Protein Kinase 5 or Serine/Threonine Protein Kinase Aurora B o ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States, World
Mitogen Activated Protein Kinase 3 (ERT2 or Insulin Stimulated MAP2 Kinase or Extracellular Signal Regulated Kinase 1 or MAP Kinase Isoform p44 or Microtubule Associated Protein 2 Kinase or p44 ERK1 or MAPK3 or EC 2.7.11.24) - Pipeline Review, H2 2016

Mitogen Activated Protein Kinase 3 (ERT2 or Insulin Stimulated MAP2 Kinase or Extracellular Signal Regulated Kinase 1 or MAP Kinase Isoform p44 or Microtubule Associated Protein 2 Kinase or p44 ERK1 or MAPK3 or EC 2.7.11.24) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Mitogen Activated Protein Kinase 3 (ERT2 or Insulin Stimulated MAP2 Kinase or Extracellular Signal Regulated Kinase 1 or MAP Kinase Isoform p44 or Microtubule Associated Protein 2 Kinase or p44 ERK1 o ...

  • Industries : Therapy, Pharmaceutical
  • Countries : World
Receptor Tyrosine Protein Kinase ERBB 3 (Proto Oncogene Like Protein c ErbB 3 or Tyrosine Kinase Type Cell Surface Receptor HER3 or HER3 or ERBB3 or EC 2.7.10.1) - Pipeline Review, H2 2016

Receptor Tyrosine Protein Kinase ERBB 3 (Proto Oncogene Like Protein c ErbB 3 or Tyrosine Kinase Type Cell Surface Receptor HER3 or HER3 or ERBB3 or EC 2.7.10.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Receptor Tyrosine Protein Kinase ERBB 3 (Proto Oncogene Like Protein c ErbB 3 or Tyrosine Kinase Type Cell Surface Receptor HER3 or HER3 or ERBB3 or EC 2.7.10.1) - Pipeline Review, H2 2016 Summary Global ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States
Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H2 2016

Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H2 2016 Summary Global Markets ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States
Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) - Pipeline Review, H2 2016

Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Tyrosine Protein Kinase CSK (C Src Kinase ...

  • Industries : Cancer, Pathology, Therapy, Pharmaceutical
  • Countries : United States
Rho Associated Protein Kinase 2 (Rho Kinase 2 or Rho Associated Coiled Coil Containing Protein Kinase 2 or p164 ROCK 2 or ROCK2 or EC 2.7.11.1) - Pipeline Review, H2 2016

Rho Associated Protein Kinase 2 (Rho Kinase 2 or Rho Associated Coiled Coil Containing Protein Kinase 2 or p164 ROCK 2 or ROCK2 or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Rho Associated Protein Kinase 2 (Rho Kinase 2 or Rho Associated Coiled Coil Containing Protein Kinase 2 or p164 ROCK 2 or ROCK2 or EC 2.7.11.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ...

  • Industries : Pathology, Pharmaceutical, Biopharmaceutical
  • Countries : United States
HIV 1 Integrase (EC 2.7.7.) - Pipeline Review, H2 2016

HIV 1 Integrase (EC 2.7.7.) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

HIV 1 Integrase (EC 2.7.7.) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘HIV 1 Integrase (EC 2.7.7.) - Pipeline Review, H2 2016’, provides in depth analysis on HIV 1 Integrase (EC ...

  • Industries : Therapy
  • Countries : United States
Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) - Pipeline Review, H2 2016

Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Alpha Synuclein (Non A Beta ...

  • Industries : Mental Health, Pathology
  • Countries : United States
Aurora Kinase A (Aurora 2 or Serine/Threonine Protein Kinase 15 or Serine/Threonine Protein Kinase 6 or Serine/Threonine Protein Kinase Aurora A or Aurora/IPL1 Related Kinase 1 or AURKA or EC 2.7.11.1) - Pipeline Review, H2 2016

Aurora Kinase A (Aurora 2 or Serine/Threonine Protein Kinase 15 or Serine/Threonine Protein Kinase 6 or Serine/Threonine Protein Kinase Aurora A or Aurora/IPL1 Related Kinase 1 or AURKA or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Aurora Kinase A (Aurora 2 or Serine/Threonine Protein Kinase 15 or Serine/Threonine Protein Kinase 6 or Serine/Threonine Protein Kinase Aurora A or Aurora/IPL1 Related Kinase 1 or AURKA or EC 2.7.11.1) ...

  • Industries : Cancer, Pathology, Therapy, Pharmaceutical
  • Countries : United States, China
Neutrophil Elastase (Bone Marrow Serine Protease or Elastase 2 or Medullasin or PMN Elastase or Human Leukocyte Elastase or ELANE or EC 3.4.21.37) - Pipeline Review, H2 2016

Neutrophil Elastase (Bone Marrow Serine Protease or Elastase 2 or Medullasin or PMN Elastase or Human Leukocyte Elastase or ELANE or EC 3.4.21.37) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Neutrophil Elastase (Bone Marrow Serine Protease or Elastase 2 or Medullasin or PMN Elastase or Human Leukocyte Elastase or ELANE or EC 3.4.21.37) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ...

  • Industries : Therapy, Pathology, Pharmaceutical, Chronic Disease
  • Countries : United States, World
RAC Gamma Serine/Threonine Protein Kinase (Protein Kinase Akt 3 or Protein Kinase B Gamma or RAC PK Gamma or STK 2 or AKT3 or EC 2.7.11.1) - Pipeline Review, H2 2016

RAC Gamma Serine/Threonine Protein Kinase (Protein Kinase Akt 3 or Protein Kinase B Gamma or RAC PK Gamma or STK 2 or AKT3 or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

RAC Gamma Serine/Threonine Protein Kinase (Protein Kinase Akt 3 or Protein Kinase B Gamma or RAC PK Gamma or STK 2 or AKT3 or EC 2.7.11.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : World, United States
TAR DNA Binding Protein 43 (TDP43 or TARDBP) - Pipeline Review, H2 2016

TAR DNA Binding Protein 43 (TDP43 or TARDBP) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

TAR DNA Binding Protein 43 (TDP43 or TARDBP) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘TAR DNA Binding Protein 43 (TDP43 or TARDBP) - Pipeline Review, H2 2016’, provides in depth ...

  • Industries : Mental Health, Pathology, Drug Discovery and Development, Therapy
  • Countries : World, United States, Germany
Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Pipeline Review, H2 2016

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Granulocyte Macrophage Colony Stimulating ...

  • Industries : Biological Therapy, Therapy, Biotechnology, Pathology
  • Countries : United States
Mitogen Activated Protein Kinase 1 (ERT1 or MAP Kinase Isoform p42 or Extracellular Signal Regulated Kinase 2 or Mitogen Activated Protein Kinase 2 or MAPK1 or EC 2.7.11.24) - Pipeline Review, H2 2016

Mitogen Activated Protein Kinase 1 (ERT1 or MAP Kinase Isoform p42 or Extracellular Signal Regulated Kinase 2 or Mitogen Activated Protein Kinase 2 or MAPK1 or EC 2.7.11.24) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Mitogen Activated Protein Kinase 1 (ERT1 or MAP Kinase Isoform p42 or Extracellular Signal Regulated Kinase 2 or Mitogen Activated Protein Kinase 2 or MAPK1 or EC 2.7.11.24) - Pipeline Review, H2 2016 ...

  • Industries : Therapy, Cancer, Pathology
  • Countries : United States, World
Serine/Threonine Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or Cell Cycle Checkpoint Kinase or CHEK1 or EC 2.7.11.1) - Pipeline Review, H2 2016

Serine/Threonine Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or Cell Cycle Checkpoint Kinase or CHEK1 or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Serine/Threonine Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or Cell Cycle Checkpoint Kinase or CHEK1 or EC 2.7.11.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ...

  • Industries : Cancer, Therapy, Pathology
  • Countries : World, United States
2016-2021 Japan Hospital Microbiology Testing Market

2016-2021 Japan Hospital Microbiology Testing Market

  • $ 3500
  • Industry report
  • November 2016
  • by Venture Planning Group

This new report from VPGMarketResearch contains 891 pages, 75 tables, and presents a comprehensive analysis of the Japanese hospital microbiology testing market, including:  Major issues pertaining to ...

  • Industries : Pathology
  • Countries : Japan
2016-2021 Future Horizons and Growth Strategies in the Japanese Hospital Tumor Marker Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

2016-2021 Future Horizons and Growth Strategies in the Japanese Hospital Tumor Marker Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 3500
  • Industry report
  • November 2016
  • by Venture Planning Group

This new report from VPGMarketResearch contains 537 pages, 42 tables, and presents a comprehensive analysis of the Japanese hospital tumor marker testing market, including:  Major issues pertaining to ...

  • Industries : Cancer
  • Countries : Japan
2016-2021 Japan Hospital Microbiology Market Forecasts: Supplier Shares by Test, Competitive Strategies

2016-2021 Japan Hospital Microbiology Market Forecasts: Supplier Shares by Test, Competitive Strategies

  • $ 3500
  • Industry report
  • November 2016
  • by Venture Planning Group

This new report from VPGMarketResearch.com contains 891 pages, 75 tables, and presents a comprehensive analysis of the Japanese hospital microbiology testing market, including:  Major issues pertaining ...

  • Industries : Pathology
  • Countries : Japan
2016-2021 Future Horizons and Growth Strategies in the Japanese Hospital Microbiology Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

2016-2021 Future Horizons and Growth Strategies in the Japanese Hospital Microbiology Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 3500
  • Industry report
  • November 2016
  • by Venture Planning Group

This new report from VPGMarketResearch.com contains 891 pages, 75 tables, and presents a comprehensive opportunities in the Japanese hospital microbiology testing market, including:  Major issues pertaining ...

  • Industries : Pathology
  • Countries : Japan
2016-2021 Future Horizons and Growth Strategies in the Global CA Tumor Markers Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

2016-2021 Future Horizons and Growth Strategies in the Global CA Tumor Markers Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

  • $ 3500
  • Industry report
  • November 2016
  • by Venture Planning Group

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the ...

  • Industries : Diagnostics
About 228000 reports

Download Unlimited Documents from Trusted Public Sources

Hospital Industry in the US

  • February 2017
    10 pages
  • Hospital  

  • United States  

View report >

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.